RxDoctor Payments Data

Brian Collins

Radiation Oncology · Washington, DCNPI 1417956640

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Accuray Incorporated at 53.8% of the total. Reporting peaked in 2022 at $16,244 and has fallen 97.8% since, to $357 in 2025.

$26,517in general payments, 2019–2025

Across 56 payments — averaging $473.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Accuray Incorporated$14K
  • Mevion_medical_systems_inc$10K
  • Zap Surgical Systems, Inc.$773
  • Siemens Medical Solutions USA, Inc.$466
  • Reflexion Medical, Inc.$378
  • Viewray Technologies Inc$280
  • plus $765 from 8 others

What the payments were for

  • Speaking & faculty fees$14,70055%
  • Travel & lodging$7,50028%
  • Food & beverage$4,07215%
  • Gifts$2451%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,517 in reported general payments places this provider in the 85th percentile of 25 radiation oncology providers in District of Columbia.

See all radiation oncology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$105,994
Medicare patients
136
Services billed
1,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →